Notice2023-06226
Agency Information Collection Activities: Proposed Collection; Comment Request
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 27, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Medicare & Medicaid Services
Abstract
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 58 (Monday, March 27, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 58 (Monday, March 27, 2023)]
[Notices]
[Pages 18141-18142]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-06226]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers CMS-10221 and CMS-10788]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments must be received by May 26, 2023.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
<a href="http://www.regulations.gov">http://www.regulations.gov</a>. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number:__ Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: <a href="https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing">https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing</a>.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-10221 Independent Diagnostic Testing Facilities (IDTFs) Site
Investigation Collection
CMS-10788 Prescription Drug and Health Care Spending
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Extension of currently
approved collection; Title of Information Collection: Independent
Diagnostic Testing Facilities (IDTFs) Site Investigation Collection;
Use: The purpose of the site investigation is to ensure that the IDTF
is in compliance with the provisions of 42 CFR 410.33, as well as all
other applicable Federal, State and local laws and regulations. It is
also used to verify the information the IDTF furnished on its CMS- 855B
enrollment application. Sections 1814(a), 1815(a), and 1833(e) of the
Act require the submission of information necessary to determine the
amounts due
[[Page 18142]]
to a provider or other person. To fulfill this requirement, CMS must
collect information on any IDTF supplier who submits a claim to
Medicare or who applies for a Medicare billing number before allowing
the IDTF to enroll. This information must, minimally, clearly identify
the provider and its' place of business as required by CFR 424.500
(Requirements for Establishing and Maintaining Medicare Billing
Privileges) and provide all necessary documentation to show they are
qualified to perform the services for which they are billing. The site
inspection form allows inspectors to verify the information using a
standardized information collection methodology. Form Number: CMS-10221
(OMB control number: 0938-1029); Frequency: Occasionally; Affected
Public Sector: Private Sector (Business or other for-profits and Not-
for-profit institutions); Number of Respondents: 652; Total Annual
Responses: 652; Total Annual Hours: 1,304. (For policy questions
regarding this collection contact Angelika Broznowicz at 410-786-8242).
2. Type of Information Collection Request: Revision of currently
approved collection; Title of Information Collection: Prescription Drug
and Health Care Spending; Use: On December 27, 2020, the Consolidated
Appropriations Act, 2021 (CAA) was signed into law. Section 204 of
Title II of Division BB of the CAA added parallel provisions at section
9825 of the Internal Revenue Code (the Code), section 725 of the
Employee Retirement Income Security Act (ERISA), and section 2799A-10
of the Public Health Service Act (PHS Act) that require group health
plans and health insurance issuers offering group or individual health
insurance coverage to annually report to the Department of the
Treasury, the Department of Labor (DOL), and the Department of Health
and Human Services (HHS) (collectively, ``the Departments'') certain
information about prescription drug and health care spending, premiums,
and enrollment under the plan or coverage. This information will
support the development of public reports that will be published by the
Departments on prescription drug reimbursements for plans and coverage,
prescription drug pricing trends, and the role of prescription drug
costs in contributing to premium increases or decreases under the plans
or coverage. The 2021 interim final rules, ``Prescription Drug and
Health Care Spending'' (2021 interim final rules), issued by the
Departments and the Office of Personnel Management (OPM) implement the
provisions of section 9825 of the Code, section 725 of ERISA, and
section 2799A-10 of the PHS Act, as enacted by section 204 of Title II
of Division BB of the CAA. OPM joined the Departments in issuing the
2021 interim final rules, requiring Federal Employees Health Benefits
(FEHB) carriers to report information about prescription drug and
health care spending, premiums, and plan enrollment in the same manner
as a group health plan or health insurance issuer offering group or
individual health insurance coverage. Form Number: CMS-10788 (OMB
control number: 0938-1407); Frequency: Annually; Affected Public
Sector: Private Sector (Business or other for-profits and Not-for-
profit institutions); Number of Respondents: 356; Total Annual
Responses: 356; Total Annual Hours: 764,442. (For policy questions
regarding this collection contact Christina Whitefield at 202-536-
8676.)
Dated: March 21, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2023-06226 Filed 3-24-23; 8:45 am]
BILLING CODE 4120-01-P
</pre></body>
</html>Indexed from Federal Register on March 27, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.